Clinical Trial Detail

NCT ID NCT03745352
Title Pevonedistat With Azacitidine Versus Azacitidine Alone in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

acute myeloid leukemia

Therapies

Azacitidine

Azacitidine + MLN4924

Age Groups: adult senior

No variant requirements are available.